mRNA structural dynamics shape Argonaute-target interactions
Suzan Ruijtenberg ( University Medical Centre Utrecht)
Stijn Sonneveld ( University Medical Centre Utrecht)
Tao Ju Cui (Kavli institute of nanoscience Delft, TU Delft - Applied Sciences)
Ive Logister ( University Medical Centre Utrecht)
Dion de Steenwinkel ( University Medical Centre Utrecht)
Yao Xiao (The Scripps Research Institute, La Jolla)
Ian J. MacRae (The Scripps Research Institute, La Jolla)
Chirlmin Joo (Kavli institute of nanoscience Delft, TU Delft - Applied Sciences)
Marvin E. Tanenbaum ( University Medical Centre Utrecht)
More Info
expand_more
Abstract
Small interfering RNAs (siRNAs) promote RNA degradation in a variety of processes and have important clinical applications. siRNAs direct cleavage of target RNAs by guiding Argonaute2 (AGO2) to its target site. Target site accessibility is critical for AGO2-target interactions, but how target site accessibility is controlled in vivo is poorly understood. Here, we use live-cell single-molecule imaging in human cells to determine rate constants of the AGO2 cleavage cycle in vivo. We find that the rate-limiting step in mRNA cleavage frequently involves unmasking of target sites by translating ribosomes. Target site masking is caused by heterogeneous intramolecular RNA-RNA interactions, which can conceal target sites for many minutes in the absence of translation. Our results uncover how dynamic changes in mRNA structure shape AGO2-target recognition, provide estimates of mRNA folding and unfolding rates in vivo, and provide experimental evidence for the role of mRNA structural dynamics in control of mRNA-protein interactions.